# Nationwide Multicentric Analysis Regarding In-Hospital Complications After Catheter Ablation of Cardiac Arrhythmias

**Authors:** Florian Doldi, Christian Meyer, Johannes Brachmann, Fabienne Kreimer, Thorsten Lewalter, Roland Tilz, Malte Kuniss, Ibrahim Akin, Philipp Sommer, Thomas Riemer, Jochen Senges, Lars Eckardt

PMC · DOI: 10.3390/jcdd13030134 · Journal of Cardiovascular Development and Disease · 2026-03-11

## TL;DR

This study analyzed in-hospital complications after catheter ablation for heart rhythm disorders in Germany, finding that ventricular tachycardia ablations had the highest risk.

## Contribution

A nationwide multicenter analysis of ablation complications using administrative data, revealing specific risks for different arrhythmia types.

## Key findings

- VT ablations had the highest complication rate (9.8%) and in-hospital mortality (2.4%).
- Pericardial tamponade was most common in VT ablations (4.0%).
- Overall complication rates were low (2.2%), with AF and AFL having lower risks than VT.

## Abstract

Objective and Background: With the increasing use of catheter ablation for tachyarrhythmias, continuous evaluation of in-hospital complications is essential. This study aimed at analyzing complications associated with catheter ablation for atrial fibrillation (AF), atrial flutter (AFL), and ventricular tachycardia (VT) using nationwide administrative data. Methods: We conducted a retrospective multicentric data analysis from large German ablation centers between 2018 and 2023. Patients were identified using ICD and OPS codes for AF, AFL, and VT regarding predefined in-hospital complications: mortality, stroke, pericardial tamponade, pulmonary embolism, and vascular complications requiring intervention. Results: Among 19,258 ablation procedures from 11 centers, AF was most common (n = 12,241), followed by AFL (n = 5582) and VT (n = 1435). Major complications occurred in 2.2% (n = 433) of cases. VT ablations had the highest complication rate (9.8%), followed by AF (1.6%) and AFL (1.7%). Pericardial tamponade occurred in 0.9% patients, most commonly in VT ablations (4.0%). Vascular complications requiring intervention were reported in 1.1%, while stroke (0.3%) and pulmonary embolism (0.05%) were rare. In-hospital mortality was highest in VT patients (2.4%), compared to AF (0.08%) and AFL (0.13%). Higher AFL mortality as compared to AF was associated with older age and more comorbidities. Upon exploratory analysis, no statistical association between hospital volume and complication rates could be seen. Conclusions: In this multicenter analysis, catheter ablation was associated with a low overall complication rate. VT ablations carried the highest risk, highlighting the impact of structural heart disease and comorbidities.

## Linked entities

- **Diseases:** atrial fibrillation (MONDO:0004981), atrial flutter (MONDO:0005310), ventricular tachycardia (MONDO:0005477)

## Full-text entities

- **Diseases:** atypical flutter (MESH:D054141), supraventricular tachycardias (MESH:D013617), deep vein thrombosis (MESH:D020246), diabetes (MESH:D003920), tachyarrhythmias (MESH:D013610), Cardiac, Cerebrovascular and Bleeding Events (MESH:D002318), OPS (MESH:C536063), acute MI (MESH:D000208), AFL (MESH:D001282), heart disease (MESH:D006331), death (MESH:D003643), obesity (MESH:D009765), stroke (MESH:D020521), Vascular complications (MESH:D003925), injury to (MESH:D014947), infections (MESH:D007239), bleeding (MESH:D006470), hyperlipoproteinemia (MESH:D006951), chronic kidney disease (MESH:D051436), Cardiac Arrhythmias (MESH:D001145), kidney failure (MESH:D051437), VT (MESH:D017180), heart failure (MESH:D006333), Complications (MESH:D008107), thromboembolic (MESH:D013923), PE (MESH:D011655), Pericardial tamponade (MESH:D002305), malignancies (MESH:D009369), acute myocardial infarction (MESH:D009203), cardiac and cerebrovascular (MESH:D002561), AF (MESH:D001281)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026731/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026731/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026731/full.md

---
Source: https://tomesphere.com/paper/PMC13026731